Efficacy of rituximab in thymoma associated minimal change disease: case report

Efficacy of rituximab in thymoma associated minimal change disease: case report

Abstract Background Thymomas have been associated with a broad spectrum of autoimmune diseases. Minimal change disease (MCD) is the most frequent pathological lesion reported. Pathophysiological mechanisms involved in secondary MCD, and linking MCD to thymoma are not yet fully explained, although th...

Full description

Bibliographic Details
Main Authors: Zhour El Ouafi, Clovis Mugnier, Robin Jeannet, Clément Danthu, Marion Duval, Valère Belle Mbou, Fatouma Touré
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Nephrology
Subjects:
Glomerulonephritis
Minimal change disease
Thymoma
Rituximab
Online Access:https://doi.org/10.1186/s12882-021-02479-8

Internet

https://doi.org/10.1186/s12882-021-02479-8

Similar Items